| Absorption | 
      | Blood-Brain Barrier | BBB+ | 0.8178 | 
      | Human Intestinal Absorption | HIA+ | 0.9857 | 
      | Caco-2 Permeability | Caco2+ | 0.5401 | 
      | P-glycoprotein Substrate | Non-substrate | 0.7596 | 
      | P-glycoprotein Inhibitor | Non-inhibitor | 0.8803 | 
                                                     | Non-inhibitor | 0.9818 | 
      | Renal Organic Cation Transporter | Non-inhibitor | 0.8979 | 
        
            | Distribution | 
        
      | Subcellular localization | Mitochondria | 0.5657 | 
        
          | Metabolism | 
        
      | CYP450 2C9 Substrate | Non-substrate | 0.6949 | 
      | CYP450 2D6 Substrate | Non-substrate | 0.8866 | 
      | CYP450 3A4 Substrate | Non-substrate | 0.7066 | 
      | CYP450 1A2 Inhibitor | Non-inhibitor | 0.9045 | 
      | CYP450 2C9 Inhibitor | Non-inhibitor | 0.9071 | 
        | CYP450 2D6 Inhibitor | Non-inhibitor | 0.9405 | 
      | CYP450 2C19 Inhibitor | Non-inhibitor | 0.9025 | 
      | CYP450 3A4 Inhibitor | Non-inhibitor | 0.8309 | 
      | CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7612 | 
        
          | Excretion | 
        
        
          | Toxicity | 
        
      | Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9611 | 
                                                                    | Non-inhibitor | 0.8328 | 
      | AMES Toxicity | Non AMES toxic | 0.7300 | 
      | Carcinogens | Non-carcinogens | 0.8187 | 
      | Fish Toxicity | Low FHMT | 0.6442 | 
      | Tetrahymena Pyriformis Toxicity | High TPT | 0.6134 | 
      | Honey Bee Toxicity | Low HBT | 0.7989 | 
      | Biodegradation | Not ready biodegradable | 0.9960 | 
      | Acute Oral Toxicity | III | 0.8004 | 
      | Carcinogenicity (Three-class) | Non-required | 0.5426 |